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EBV DNA contains G-rich, repeat regions that are involved in rearrangement and recombination events including terminal
repeat (TR) processing and the EBNA-2 deletion in the EBV strain P3HR-1. Cellular proteins, called terminal or tandem
repeat binding proteins (TRBPs), recognize sequences at the junctions of these recombination events. In this study, using
antibody supershift assays and expression of recombinant proteins, we show that Sp1 and Sp3 are the sequence-specific
components of TRBP and that Ku is the nonspecific binding component. Sp1 binds other recombinogenic regions of EBV
DNA, but Sp3 does not bind to the large internal repeat. The sequence GGGGTGGGG, a low affinity site for Sp1 and Sp3,
is the minimal binding site within terminal repeat binding site 1 (TRBS1). However, 3* flanking sequences in the sequence
GGGGTGGGGCATGGGG augment binding of Sp1 and Sp3 so that their affinity of binding is increased approximately twofold
relative to a classical high-affinity Sp1 site. EBV lytic cycle induction does not alter the abundance or binding activity of
any of the three identified components of TRBP. Sp1 and Sp3 may act in trans to promote EBV terminal repeat processing
and possibly other viral and cellular recombination events. q 1997 Academic Press
INTRODUCTION lines protected three regions of the EBV TR. We called
these protected regions terminal repeat binding site
The genome of Epstein–Barr virus (EBV) can adopt (TRBS) 1, TRBS2, and TRBS3. TRBS1 encompasses the
two conformations. In the virion, the genome is packaged 11-bp sequence, GGGGCATGGGG, involved in TR pro-
as a linear duplex DNA molecule (Hammerschmidt and cessing. Furthermore, we showed that TRBS1 was recog-
Sugden, 1988). In the cell, the genome exists as a circular nized by proteins in nuclear extracts from various
episome (Adams and Lindahl, 1975; Gardella et al., 1984; sources by electrophoretic mobility shift assays (EMSA).
Gussander and Adams, 1984; Nonoyama and Pagano, We called these proteins terminal repeat binding pro-
1972). The interconversion of the viral genome between teins (TRBP). Nuclear extracts from bovine, murine, pri-
its linear and its circular forms is mediated through the mate, and trypanosome cells from various tissues con-
terminal repeats (TRs) (Given et al., 1979; Kintner and tained TRBPs, indicating that TRBPs are conserved and
Sugden, 1979b). Although the mechanism of TR pro- ubiquitously expressed. By EMSA, TRBP formed three
cessing is unknown, sequencing of the termini of pack- DNA–protein complexes designated A, B, and C, in order
aged, linear DNA revealed extensive rearrangements of of increasing electrophoretic mobility. Competition and
the TRs relative to the fused termini found in circular or DNA binding-site mutation experiments showed that the
concatameric DNA. At the right terminus of the linearized DNA binding components of complexes A and B recog-
TRs there was duplication of an 11-bp sequence, GGG- nized DNA in a sequence-specific manner. Complex C
GCATGGGG, and insertion of a 9-bp element, GTGTTG-
proteins bound DNA nonspecifically (Sun et al., 1994).
GCG, which is derived from unique sequences (Zimmer-
TRBPs also recognized other tandemly repeated se-
mann and Hammerschmidt, 1995). A thymine also ap-
quences involved in rearrangements of the EBV and cel-pears to have been deleted from the point of attachment
lular genomes. Sequences in the EBV BamHI W repeatsof the 9-bp element to the remainder of TR sequences
and BamHI H fragments at the recombination junction(Sun et al., 1997).
of the HR-1 Epstein–Barr nuclear antigen 2 (EBNA-2)We had previously described proteins that bound to
deletion (Jeang and Hayward, 1983) were recognized bythe TRs at or near the ends of EBV DNA (Sun et al., 1997,
TRBP. Cellular recombinogenic tandemly repeated se-1994; Zimmermann and Hammerschmidt, 1995). Nuclear
quences, such as switch region sequences of the immu-extracts from EBV-positive human B-lymphocyte cell
noglobulin gamma 3 gene (Sg3) and variable number
tandem repeat sequences, were also bound by TRBPs
(Sun et al., 1994).1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (203) 785-6961. E-mail: George_Miller@qm.yale.edu. We recently found that one of the components of TRBP
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was Sp1. Sp1, over-expressed in HeLa cells infected with Lymphocyte cell lines were chemically treated with
a combination of 12-O-tetradecanoylphorbol-13-acetaterecombinant vaccinia virus containing the entire Sp1 cod-
ing sequence, protected TRBS1 and TRBS2 from DNaseI (TPA) and sodium butyrate at final concentrations of 20
ng/ml and 3 mM, respectively. Cell cultures were ex-digestion. Sp1 formed a complex with mobility similar
to complex A. Moreover, complex A, formed by nuclear posed to the drugs for 4 days and harvested to prepare
nuclear extracts and cellular extracts in parallel.extract, was partially supershifted by antibodies to Sp1
(Sun et al., 1997). However, several considerations were Vectors for expression of recombinant Sp1 and Sp3,
pPacSp1 (Courey and Tjian, 1988) and pPacSp3 (Hagennot addressed by that recent report. The other proteins
that bound to TRBS1 and were responsible for formation et al., 1994), were kindly provided by R. Tjian and G.
Suske, respectively. SL2 cells (Schneider, 1972) wereof complexes B and C were not identified. The protein
responsible for residual activity in complex A that was maintained in Schneider’s Drosophila Medium (Gibco
BRL, Grand Island, NY) supplemented with 12.5% fetalnot affected by antibody to Sp1 was not known. It was
not known whether all the components of TRBP bound bovine serum, penicillin, streptomycin, and fungizone at
257. SL2 cells were transfected by the calcium phosphatewith equal affinity to different recombinogenic sequences
within EBV. Moreover, no known high affinity Sp1 sites method (Di Nocera and Dawid, 1983) at densities of ap-
proximately 2 1 106 cells/ml, 107 cells/plate. Each platewere present in TRBS1; thus the question still remained
how Sp1 was being directed to TRBS1. received 12 mg pPacSp1 or pPacSp3 DNA. Cells were
harvested 48 hr later to prepare nuclear extracts.In this report, we identified the remaining components
of the TRBP complexes. The sequence-specific TRBP All nuclear extracts were prepared as described pre-
viously (Sun et al., 1994). Nuclear extracts were depletedcomponent, in addition to Sp1, was the transcription re-
pressor Sp3; the nonspecific DNA binding component of Sp1 and Sp3 by immunoprecipitation using monospe-
cific antibodies against Sp1 and Sp3 as described pre-was the autoantigen Ku. Within the footprinted TR site,
TRBS1, we determined that the contact site of Sp1 and viously (Craft and Hardin, 1992). Cellular extracts were
prepared by sonicating 106 cells in Laemmli’s SDS–PAGESp3 was GGGGTGGGG. The contact site was flanked
by sequences that contained an additional G-tract that sample buffer. Samples were boiled for 5 min at 1007.
increased the affinity of Sp1 and Sp3 for TRBS1. The
Electrophoretic mobility shift assay (EMSA)effects of EBV lytic cycle activation on these factors were
also examined; activation did not appear to affect the Single-stranded oligonucleotides were annealed and
radiolabeled by filling in recessed 3* ends using Klenowlevels of the TRBP factors.
fragment of DNA polymerase I (Boehringer Mannheim,
Indianapolis, IN) and [a32P]dCTP (Amersham Corpora-MATERIALS AND METHODS
tion, Arlington Heights, IL). EMSA and supershift assays
Reagents were as previously described (Sun et al., 1994) with the
following exceptions. For the EMSA competition, 2.5 1Rabbit polyclonal anti-Sp1, (PEP2)X TransCruz and
104 cpm of 32P-labeled duplex probe was brought to aanti-Sp3, (D-20)X TransCruz were purchased from Santa
concentration of 5 nM with unlabeled duplex DNA, andCruz Biotechnology (Santa Cruz, CA). Monoclonal anti-
competitor nucleotide was added at the indicated foldbodies, N3H10 to Ku p70 and 111 to Ku p80, were kindly
increase relative to 5 nM. For the comparison of bindingprovided by Dr. Westley Reeves (Wang et al., 1993). SC
activities in induced and uninduced cell lines, 7 mg ofserum is from a patient with chronic active EBV infection
total protein was added to the binding reactions. Com-that recognizes lytic EBV antigens (Miller et al., 1987).
plexed and free probe was resolved on either a verticalRM serum is from a person that previously had infectious
5% polyacrylamide gel or a horizontal 2% Trevigel (Trevi-mononucleosis; this serum contains antibody to EBNAs
gen, Gaithersburg, MD).(Grogan et al., 1983).
Quantitation and analysis of EMSA competitions
Cell lines and preparation of extracts
DNA binding activity as assessed by EMSA was quanti-
tated by phosphorimagery. Percentage shifted  [(countsLymphocyte cell lines were grown in Roswell Park
Memorial Institute (RPMI) 1640 medium supplemented contained in the shifted band)/(total counts in gel lane)]
1 100. In duplex DNA competition assays the effect ofwith 8% fetal bovine serum, penicillin, streptomycin, and
fungizone. HR-1 cl16 (Rabson et al., 1983) and Daudi the competitor was expressed as a competition index (CI).
CI  (Percentage shifted in the presence of competitor)/(Klein et al., 1968) are EBV-positive human B-cell lines
that are deleted for most of the EBNA-2 gene. Raji is an (percentage shifted in absence of competitor).
EBV-positive human B-cell line that contains a defective
Immunoblottinggenome which prevents late gene expression (Pulvertaft,
1964). B95-8 is an EBV-transformed marmoset B-cell line Samples were resolved by 8% SDS–PAGE and electro-
phoretically transferred to nitrocellulose (0.45 mm,(Miller and Lipman, 1973).
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FIG. 1. Identification of components of TRBP by an EMSA supershift assay. (A) The sequences of probes T, W, and H that are used with EMSA.
EBV sequences are in bold. (B) Probes T, W, and H were incubated with Raji nuclear extracts (lanes 2, 7, and 12, respectively). TRBP complexes
are labeled A, A*, B, and C; supershift complex, S; free probe, P. Lanes 1, 6, and 11 contain probe alone. The addition of monospecific Sp1 antibody
supershifted complex A (lanes 3, 8, and 13). Monospecific Sp3 antibody eliminated complexes A* and B on probes T and H (lanes 4 and 14), on
probe W, bands A* and B were not affected by anti-Sp3 (lane 9). Monoclonal antibody against Ku p80 supershifted band C (lanes 5, 10, and 15).
(C) Probe W was assayed for binding activity with either Sp1-depleted B-cell nuclear extracts (lanes 2–4) or Sp3-depleted extracts (lanes 5–7).
TRBP complexes are labeled A and C; the B-like complex on probe W is labeled B*; supershift complex, S; free probe, P. Lane 1 contains the probe
alone. Complexes formed by each extract were tested for recognition by anti-Sp1 (lanes 3 and 6) and anti-Sp3 (lanes 4 and 7).
Schleicher & Schuell, Keene, NH). Membranes were plexes that were contained in complex A. We called the
blocked overnight in 5% skim milk and probed for 1 hr second complex A* (Fig. 1B, lane 2). TRBP complexes
with primary antibodies. For mouse monoclonal primary A, A*, and B bound DNA in a sequence-specific manner.
antibodies, blots were additionally incubated with rabbit However, complex C appeared to bind the probes non-
anti-mouse IgG. After two 10-min washes at room tem- specifically.
perature with Tris-saline (0.9% (w/v) NaCl), the blot was Using monospecific antibodies, we identified the
incubated with 125I-labeled protein A. The blot was then components of these complexes by EMSA supershift
washed for 10 min in Tris–saline at room temperature assays. Anti-Sp1 supershifted complex A (lane 3). We
and autoradiographed. therefore deduced that the other specific complexes
may contain Sp1-like proteins. Figure 1B, lane 4, shows
RESULTS that anti-Sp3 interfered with the formation of complexes
A* and B. It had previously been reported that TRBPs
TRBP complexes contain Sp1, Sp3, and Ku are autoantigens (Sun et al., 1994). Since Ku is com-
monly associated with DNA-binding autoantigens weTRBPs from nuclear extracts of various B-cell lines
also examined the possibility that Ku might be a compo-consistently formed three complexes with duplex probes
nent of TRBP. Human autoantisera, reactive to Ku, su-derived from tandemly repeated sequences that are in-
pershifted complex C (Spain et al., 1997). To confirmvolved in EBV genome rearrangements (Fig. 1A). We
that Ku was in fact contained in complex C, we addedlabeled these complexes A, B, and C, in order of increas-
monoclonal antibody against Ku p80 to the EMSA bind-ing mobility. Resolving TRBP complexes on a horizontal
ing reaction. Anti-Ku supershifted TRBP complex C (Fig.apparatus using a nonpolyacrylamide matrix (see Mate-
rials and Methods) enabled separation of two com- 1B, lane 5).
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Identification of components in TRBP complexes
formed on different tandem repeat sequences
Three probes were synthesized representing se-
quences involved in EBV genome rearrangements (Fig.
1A). Probe T was derived from TRBS1, the site in the TRs
that were protected from DNaseI digestion by nuclear
extract and Sp1 protein. This site contained sequences
that appear to be central in TR processing during the
interconversion between the circular and linear forms of
the genome (Sun et al., 1997; Zimmermann and Ham-
merschmidt, 1995). W and H represented sequences
found at the junction of the HR-1 EBNA-2 deletion in the
BamHI W and BamHI H fragments of EBV (Jeang and
Hayward, 1983).
TR sequences (Fig. 1B, lanes 1–5) and BamHI H se-
quences (Fig. 1B, lanes 11–15) were bound by com-
plexes containing Sp1, Sp3, and Ku. However, only com-
plexes A and C were formed on the BamHI W probe (Fig.
1B, lane 6–10). Complex A was supershifted by anti-Sp1 FIG. 2. Binding activity of Sp1 and Sp3 expressed in S2 cells. Probes
(Fig. 1B, lane 8) and complex C was supershifted by T (lanes 1–8) and W (lanes 9–16) were used to examine the binding
antibody to Ku (Fig. 1B, lane 10). Probe W did appear to of recombinant Sp1 (lanes 3–5 and 11–13) and Sp3 (lanes 6–8 and
14–16). Raji nuclear extract complexes were used to compare theform a complex of the same mobility as complex A*
mobilities of the complexes formed with recombinant proteins ex-formed on probes T and H (Fig. 1B, lane 8). However,
pressed in S2 Drosophila cells (lanes 2 and 10). TRBP complexes are
from the experiment described in the legend to Fig. 1C labeled A, B, and C; supershift complex, S; free probe, P. Lanes 1
it was clear that this band was not due to Sp3 binding but and 9 contain probe alone. The identities of the proteins contained in
was likely to be residual Sp1 that was not supershifted by complexes formed by each recombinant protein nuclear extract were
confirmed by supershift with anti-Sp1 (lanes 4, 7, 12, and 15) and anti-the antibody to Sp1. Furthermore, the complex formed
Sp3 (lanes 5, 8, 13, and 16).on probe W with a mobility similar to complex B, was
not affected by antibody to Sp3 (lane 9). Therefore, Sp3
did not appear to bind to probe W. nant Sp1 (Fig. 2, lanes 4 and 12), and anti-Sp3 had no
The experiment depicted in Fig. 1C confirmed that Sp3 effect on this complex (Fig. 2, lanes 5 and 13). These
did not bind to probe W. Nuclear extracts depleted of experiments confirmed that complex A contained Sp1.
Sp1 (Fig. 1C, lanes 2–4) or Sp3 (Fig. 1C, lanes 5–7) were Recombinant Sp3 strongly formed a complex on probe
examined for binding activity to W. Sp1-depleted extracts T (Fig. 2, lanes 6 and 7), with the same mobility as com-
weakly formed a complex that comigrated with complex plex B formed by B-cell nuclear extract (Fig. 2, lane 2).
A or A*, but this complex was not affected by Sp1 anti- Anti-Sp1 had no effect on the complex formed by recom-
body (Fig. 1C, lane 3) nor by Sp3 antibody (Fig. 1C, lane binant Sp3 (Fig. 2, lane 7) and anti-Sp3 interfered with
4). A complex with mobility properties similar to complex the formation of this complex (Fig. 2, lane 8). Unlike Sp1,
B formed by the Sp1-depleted extract was also unaf- recombinant Sp3 did not form a complex on probe W
fected by Sp3 antibody (Fig. 1C, lane 4). Sp3-depleted (Fig. 2, lanes 14–16). Complex A* which was formed by B-
extract still formed a B-like complex on W, labeled B* cell nuclear extract was not formed by either recombinant
(Fig. 1C, lane 5), that was not affected by antibody to Sp1 or Sp3. The complex formed by B-cell nuclear extract
Sp3. Therefore the B* complex on probe W is due to on probe W with mobility similar to complex B was not
neither Sp1 nor Sp3 (Fig. 1C, lane 7). Since Sp1 still formed by either recombinant Sp1 or Sp3. Complex C
formed a complex on W (Fig. 1C, lane 6), the binding was not formed by S2 cells or by either recombinant Sp1
ability of factors in the nuclear extract was maintained or Sp3. These experiments confirmed that Sp1 and Sp3
during the depletion procedure. bound to TRBS1, but only Sp1 bound to BamHI W.
Binding activity of Sp1 and Sp3 expressed in S2 Effect of mutagenesis of TRBS1 on the binding by
Drosophila cells components of TRBP
The next series of experiments examined the DNA-Recombinant Sp1 strongly formed complexes on probe
T (Fig. 2, lanes 3 and 5) and weakly on probe W (Fig. 2, sequence binding requirements of the components of
TRBP by use of mutants encompassing TRBS1, the locuslanes 11 and 13) with the same mobility as complex A
formed by B-cell nuclear extract (Fig. 2, lanes 2 and 10). of interconversion between linear and circular forms of
the genome in the TRs. Probes with mutations spanningAnti-Sp1 supershifted the complex containing recombi-
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FIG. 3. Identification of components of TRBP complexes formed on mutant probes. (A) The sequences of probes T, TmDL, TmDM, TmCA, and
TmDR that were used in EMSA. EBV-derived sequences are in bold. Mutant sequences are underlined. (B) Probes containing alterations in the G-
tracts and the CA sequence of probe T were incubated with B-cell nuclear extract (lanes 2, 7, 12, 17, and 22). TRBP complexes are labeled A, A*,
B, and C; supershift complex, S; free probe, P. Lanes 1, 6, 11, 16, and 21 contain probe alone. All DNA–protein complexes were tested for the
presence of Sp1 (lanes 3, 8, 13, 18, and 23), Sp3 (lanes 4, 9, 14, 19, and 24), and Ku (lanes 5, 10, 15, 20, and 25) by supershift with monospecific
antibodies.
the length of TRBS1 (Fig. 3A) were examined for their GGG, which is generally considered to be the classical
Sp1 site (Kadonaga et al., 1987). It had previously beenability to complex with TRBP components (Fig. 3B). These
experiments indicated that GGGGTGGGG was the mini- reported that GGGGTGGGG was a low-affinity Sp1 site
in comparison with the SV40-derived site (Dittmer et al.,mal binding site within TRBS1 for Sp1 and Sp3. Sp1 and
Sp3 did not recognize probes containing mutations in 1994; Kudo and Fukuda, 1994; Okumura et al., 1996). The
following experiments confirmed that the substitution ofeither the first or second G-tract of the sequence, GGG-
GTGGGG (Fig. 3A, TmDL and TmDM, and Fig. 3B, lanes cytosine with thymine is deleterious to Sp1 and Sp3 bind-
ing. These experiments examined the effects of DNA8, 9, 13, and 14). Conversely, probes in which sequences
at the 3* flank of GGGGTGGGG were mutated were effi- binding site mutations on the binding of both Sp1 and
Sp3 simultaneously.ciently bound by Sp1 and Sp3 (Fig. 3A, TmDCA and
TmDR, and Fig. 3B, lanes 18, 19, 23, and 24). Ku bound Probes containing the SV40-derived Sp1 site (Fig. 5A,
Sp1) were competed with a probe containing a C to Tto all duplex probes examined, confirming that complex
C was formed nonspecifically (Sun et al., 1994). mutation in the Sp1 site (Fig. 5A, Sp1mT); Sp1 and Sp3
bound less efficiently to the site containing the thymineEMSA experiments using duplex probes with point mu-
tations in TRBS1 (Fig. 4A) showed that only alterations (Fig. 5B). Conversely, the probe derived from TRBS1 (Fig.
5A, T) was competed with a probe containing a T to Cin the G-tracts within the sequence, GGGGTGGGG, af-
fected Sp1/Sp3 binding (Fig. 4A, Tm1A, Tm1C, and Tm3, mutation, effectively putting an SV40 Sp1 site in the context
of TRBS1 (Fig. 5A, TmSp1); again, Sp1 and Sp3 bound lessand Fig. 4B, lanes 8, 9, 18, 19, 28, and 29). Probes with
point mutations in the G-tract flanking the contact site efficiently to the probe containing the thymine (Fig. 5C).
Interestingly, when TRBS1 (Fig. 5A, T), which containedwere efficiently bound by Sp1 and Sp3 (Fig. 4A, Tm1B,
and Fig. 4B, lanes 13 and 14). A transversion, substituting the low-affinity Sp1 site, was competed with the high-affin-
the thymine in TRBS1 with adenine, did not affect Sp1/ ity SV40-derived Sp1 site (Fig. 5A, Sp1), Sp1 and Sp3 bound
Sp3 recognition of this site (Fig. 4A, Tm2, and Fig. 4B, more efficiently to TRBS1 than to the SV40-derived site
lanes 23 and 24). The data of Figs. 2 and 3 collectively (Fig. 5D). This led us to believe that, in the context of
demonstrated that Sp1 and Sp3 recognized a subsite TRBS1, sequences flanking the Sp1/Sp3 contact site aug-
within TRBS1, GGGGTGGGG, contacting the DNA within mented DNA-binding of these factors. The flanking se-
the G-tracts of this site. quence in TRBS1 contained a G-tract; however, the probe
itself was long and could provide more nonspecific contact
TRBS1 is bound more efficiently by Sp1 and Sp3 in sites that might stabilize the binding of Sp1 and Sp3.
the context of the whole TR binding site To determine whether this was a sequence-specific
effect or just the stabilizing effect of providing more non-Sp1 and Sp3 contacted the site GGGGTGGGG. This
site was similar to the SV40-derived Sp1 site, GGGGCG- specific contacts with a longer flanking sequence, the
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FIG. 4. Identification of TRBP complex components formed on point mutants of probe T, a probe that contains sequences derived from the TR.
(A) The sequences of point mutants of probe T used in EMSA. EBV sequences are in bold and mutant sequences are underlined. (B) Probes
containing point mutations in the G-tracts or adenines substituted for thymines were incubated with B-cell nuclear extract and analyzed by EMSA
(lanes 2, 7, 12, 17, 22, and 27). TRBP complexes are labeled A, A*, B, and C; supershift complex, S; free probe, P. Lanes 1, 6, 11, 16, 21, and 26
contain probe alone. All extracts were tested for Sp1 (lanes 3, 8, 13, 18, 23, and 28), Sp3 (lanes 4, 9, 14, 19, 24, and 29), and Ku (lanes 5, 10, 15,
20, 25, and 30) by supershift with monospecific antibodies.
TRBS1 site (Fig. 5A, T) was competed with a probe mutat- parallel with the nuclear extracts used in EMSA, were
immunoblotted with a human antiserum SC that recog-ing the sequences flanking the Sp1/Sp3 contact site
while preserving the length of the probe (Fig. 5A, TmDR). nized EBV lytic cycle products, early antigen D (EA-D), and
the late protein complex p21 (Fig. 6B). All of the cell linesSp1 and Sp3 were competed more efficiently by probe
T than by TmDR (Fig. 5E). Thus, in the context of TRBS1, except Raji produced increased levels of both EA-D and
p21 after chemical treatment (Fig. 6B, lanes 1–6). Sincea low-affinity Sp1/Sp3 site is bound by the Sp factors
more efficiently due to the presence of a G-tract flanking Raji is defective for late gene expression, it did not produce
p21 but still produced EA-D, indicating that this cell linethe Sp1/Sp3 contact site.
was also induced by the drug treatment (Fig. 6B, lane 8).
To confirm that the levels of protein in the immunoblot-The effects of EBV lytic cycle induction on TRBP
ting assay were not influenced by loading effects, thecomponents
extracts were immunoblotted with human antiserum RM
The EBV TRs are processed at two points in the life that recognizes the latent protein Epstein–Barr nuclear
cycle of EBV: during circularization of the viral genome; antigen 1 (EBNA-1). The level of EBNA-1 does not change
and during cleavage and encapsidation of the genome. upon induction of the lytic cycle (Weigel and Miller, 1983).
If TRBPs are involved in TR cleavage and encapsidation, Figure 6C shows that EBNA-1 levels remained constant
they might change in abundance or activity following lytic in each cell line after induction of the lytic cycle; there-
cycle activation. Therefore, we examined the binding ac- fore, comparable amounts of total protein were loaded
tivity of nuclear extracts from EBV-positive B-cell lines from both untreated and induced cells.
that were untreated or induced into lytic cycle gene ex- To examine the effect of the lytic cycle on the levels
pression with TPA and n-butyrate. Figure 6A shows that, of TRBPs, the cell extracts were probed with antibodies
although each cell line varied in the degree of TRBS1 to Sp1 (Fig. 6D), Sp3 (Fig. 6E), and Ku p70 and p80 (Fig.
binding activity present in the nuclear extract, there was 6F) in immunoblotting assays. None of these proteins
no difference between the binding activities of uninduced were appreciably affected by lytic cycle induction. In Fig.
or induced nuclear extracts. The differences in the band 6E, lanes 1 and 2, no proteins were recognized by anti-
formation patterns of nuclear extracts from different cell Sp3 in the marmoset cell line, B95-8, because this Sp3
lines are most likely due to variation in preparation of antibody did not recognize marmoset Sp3. Sp3 is charac-
nuclear extract rather than true biological differences teristically expressed as two protein products (see Dis-
among the cell lines. For this reason, we only compared cussion). Anti-Ku p80 also did not cross-react with mar-
different treatments of the same cell line rather than com- moset Ku p80 (Fig. 6F). In summary, Fig. 5 showed that
paring between cell lines. induction of the EBV lytic cycle did not affect the protein
To verify that EBV lytic activation was induced in the levels of TRBPs and did not affect the binding activity of
TRBPs to the TR.TPA/butyrate-treated cells, cellular extracts, prepared in
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FIG. 5. Competition analysis of probes derived from sequences in the EBV-TR and the SV40-derived Sp1 site. (A) The sequences of probes used
in competition analysis. Sequences thought to be required for contact with Sp1 on the basis of mutational analysis (see Fig. 2) are underlined.
Mutations are double underlined. (B–E) TRBP complexes A and A* are shown. Competition indices are defined under Materials and Methods. (B)
Competition between Sp1 and Sp1mT: labeled Sp1 (squares) competed with unlabeled Sp1 (filled squares) or Sp1mT (open squares); labeled
Sp1mT (circles) competed with unlabeled Sp1 (filled circles) or Sp1mT (open circles). (C) Competition between T and TmSp1: labeled T (squares)
competed with unlabeled T (filled squares) or TmSp1 (open squares); labeled TmSp1 (circles) competed with unlabeled T (filled circles) or TmSp1
(open circles). (D) Competition between Sp1 and T: labeled Sp1 (squares) competed with unlabeled Sp1 (filled squares) or T (open squares); labeled
T (circles) competed with unlabeled Sp1 (filled circles) or T (open circles). (E) Competition between T and TmDR: labeled T (squares) competed
with unlabeled T (filled squares) or TmDR (open squares); labeled TmDR (circles) competed with unlabeled T (filled circles) or TmDR (open circles).
DISCUSSION cules (Blier et al., 1993; Zhang and Yaneva, 1992). Our
own data confirm that Ku is binding to the EMSA probes
Identification of TRBP components
nonspecifically (Figs. 1–3). Although our data do not
prove that Ku recognizes EBV termini specifically, it alsoWe have identified the components of TRBP by EMSA
supershift analysis and expression of recombinant pro- does not exclude the possibility that Ku plays a role in
TR processing. In fact, by complexing with the DNA-de-teins. Monospecific antibodies to Sp1, Sp3, and Ku rec-
ognized complexes containing these factors: anti-Sp1 su- pendent protein kinase catalytic subunit, Ku was shown
to be involved in the phosphorylation of Sp1 (Gottliebpershifted complex A; anti-Sp3 interfered with the forma-
tion of complexes A* and B; and anti-Ku p80 supershifted and Jackson, 1993). Furthermore, Ku is known to be es-
sential for double-strand break repair and V(D)J recombi-complex C. Sp3 has previously been found to form two
complexes. The two Sp3 –DNA complexes arise from nation (Boubnov et al., 1995; Errami et al., 1996; Smider
et al., 1994; Taccioli et al., 1994; Zhu et al., 1996).several protein products that appear to be encoded by
the Sp3 gene (Fig. 6E). It is not known why Sp3 is ex-
pressed as different proteins. The proteins may represent Differences in TRBP binding to recombinogenic EBV
species of Sp3 that differ in posttranslational modification sequences
or the smaller protein may represent a truncated or de-
graded product (Hagen et al., 1994; Kingsley and Winoto, TRBPs were previously known to recognize a wide
array of viral and cellular recombinogenic sequences.1992). Recombinant Sp3 expressed in insect cells formed
complex B but not complex A* (Fig. 2). This result indi- The EBV sequences known to be recognized by TRBP
were in the TRs at the locus of rearrangement during TRcated that any modifications to Sp3 resulting in species
of different mobilities in mammalian cells were not car- processing (Sun et al., 1994; Zimmermann and Ham-
merschmidt, 1995) and sequences at the recombinationried out in insect cells.
It is not yet clear whether the binding of Ku to the junction of the HR-1 EBNA-2 deletion in the BamHI W
repeats and in BamHI H (Jeang and Hayward, 1983; Sunprobe in this assay is biologically relevant. Ku binds non-
specifically to ends of double-stranded (ds) DNA mole- et al., 1994).
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FIG. 6. EBV lytic cycle induction does not alter the abundance of TRBP components. (A) TRBP complexes are labeled A, B, and C; free probe, P.
Nuclear extracts, prepared from B95-8, HR-1 cl16, and Daudi and Raji cell lines, either untreated or treated with TPA and n-butyrate for 4 days,
were examined for binding to probe T by EMSA. (B–F) Cellular extracts of the same cell lines, prepared at the same time as nuclear extract, were
immunoblotted with the following antisera: Human serum SC, which detects early antigens (EA) and the late p21 complex (B); human serum RM,
which detects EBV latent antigens, including EBNA-1 and leader protein (LP) and the lytic late antigen complex, p21 (C), monospecific rabbit anti-
Sp1 (D), monospecific rabbit anti-Sp3 (E), and a mixture of monoclonal antibodies to Ku p70 and Ku p80 (F).
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All components of TRBP bound to the TR and to BamHI 100,000 Sp1 binding sites in the genome. The number
of Sp1 molecules per cell has been estimated to be 5,000H sequences; surprisingly, Sp1 bound BamHI W se-
quences, but Sp3 did not. It was previously thought that to 10,000 (Kadonaga et al., 1986). Hence, it is unlikely
that an excess of uncommitted Sp1 molecules exist in theSp1 and Sp3 recognize the same DNA sequences with
identical affinities. In the DNA binding domain the pro- nucleus. Therefore, EBV DNA must compete favorably for
these molecules.teins are 90% identical (Hagen et al., 1992; Kadonaga et
al., 1987; Kingsley and Winoto, 1992). Moreover, it has A comparison of the relative affinity of TRBS1 with a
classical Sp1 site (Fig. 5D) shows that TRBS1 binds Sp1been proposed that Sp3 competes Sp1 off of its DNA
binding site, and in this way represses transcription by about two times more efficiently than does the SV40-
derived Sp1 site, which is known to be one of the highestSp1 (Hagen et al., 1992; Hagen et al., 1994; Majello et
al., 1994; Majello et al., 1995). Our data provide a demon- affinity binding sites for Sp1 (Kadonaga et al., 1986). Thus,
EBV may have evolved its TR sequences to attract Sp1stration that Sp1 and Sp3 are able to recognize different
sequences. Thus, while Sp3 may compete with Sp1 for away from the cellular genome in order to capture these
molecules for the purpose of TR processing.some sites, other sites may not be recognized by Sp3.
Sp1 and Sp3 bind a low-affinity subsite within the The recombinogenic Sp1/Sp3 sites do not participate
high-affinity TR binding site 1 in initiation of transcription
Competition experiments comparing the binding affini-
Sp1 and Sp3 are both transcription factors that play
ties of TRBS1 and a classical Sp1 site showed that Sp1
a role in initiation and repression of gene expression,
and Sp3 bound TRBS1 more efficiently than the Sp1 site
respectively. We considered the possibility that the par-
(Fig. 5D). Mutational analysis of TRBS1 showed that the
ticipation of these factors in transcriptional control could
G-tracts of a subsite, GGGGTGGGG, are recognized by
be essential to the mechanism of recombination. The
Sp1 and Sp3 (Figs. 2 and 3). This sequence, GGGGTG-
sites of recombination in BamHI W (base 1709 within the
GGG, has been previously described as a low affinity
BamHI W fragment) and H (base 52450 on the B95-8
binding site as compared to the traditional Sp1 site,
genome) that were bound by these factors do not appear
GGGGCGGGG (Dittmer et al., 1994; Kudo and Fukuda,
to be associated with transcription initiation (Baer et al.,
1994; Okumura et al., 1996). Our data also showed that
1984). However, a family of leftward 3.5-kb LMP1 mRNAs
the cytosine to thymine substitution is deleterious to Sp1
initiate in the first TR adjacent to the long unique se-
and Sp3 binding (Figs. 5B and 5C). Interestingly, we found
quence, UL (Sadler and Raab-Traub, 1995). These tran-
that deleting the G-tract flanking the low-affinity contact
scripts are not thought to initiate in TRs that are further
site in TRBS1 also decreased Sp1/Sp3 binding to this
removed from UL. By contrast, neither ligation nor cleav-
site (Fig. 5E). Therefore, the sequences flanking the low
age of the genome appears to take place in the first
affinity contact site, GGGGTGGGG, within TRBS1 aug-
terminal repeat that is adjacent to unique sequences
ment the binding of Sp1 and Sp3 to this low-affinity site.
(Given et al., 1979; Kintner and Sugden, 1979a; Zimmer-
The sequence flanking the contact site within TRBS1
mann and Hammerschmidt, 1995). Moreover, the Sp1/
that augments Sp1/Sp3 binding is CATGGGG. Guanine
Sp3 sites of TRBS1 are not intact in the first TR which
tracts can form higher order structures that have been
begins within TRBS1. It is furthermore not likely that the
implicated in recombination events (Hardin et al., 1991,
Sp1 binding sites in TRBS2 are important in the initiation
1992; Sen and Gilbert, 1988, 1992; Smith and Feigon,
of the large LMP1 transcripts since they are located only
1992). Perhaps the G-tract that flanks the Sp1/Sp3 site
2–3 nucleotides from the initiation sites (Sadler and
serves the dual purpose of augmenting Sp1/Sp3 binding
Raab-Traub, 1995; Sun et al., 1994); classically Sp1 sites
and facilitating recombination by providing a wider
are arranged from 040 to 0100 from the start of tran-
stretch of DNA that can form recombinogenic DNA struc-
scription (Kadonaga et al., 1986).
tures.
The cis elements required for terminal processing are
not known; therefore it cannot be stated with certaintyCompetition between EBV DNA and cellular DNA for
that transcription initiation of the 3.5-kb LMP1 mRNAs isthe binding of Sp1
not required for ligation or linearization of the EBV ge-
nome. However, the 3.5-kb LMP1 mRNAs are not effi-Sp1 is a ubiquitous transcription factor that plays a
role in the activation of a large number of cellular genes. ciently expressed in B cells, whereas the process of
genome circularization takes place efficiently in theseIt has been estimated that the human genome contains
between 50,000 and 100,000 genes (Strachan, 1992). cells (Sadler and Raab-Traub, 1995). Therefore, it is likely
that transcription initiation of the 3.5-kb LMP1 mRNA isAbout half of these genes are associated with CpG is-
lands which are potential sites of Sp1 binding (Mortlock not involved in circularization.
Although transcription initiation does not appear to beet al., 1996). If we assume that there are two Sp1 sites
per CpG island there might be approximately 50,000 – essential for recombination at TRBS1, BamHI W or H,
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Baer, R., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrell, P. J., Gib-transcription itself may still be important in the process.
son, T. J., Hatfull, G., Hudson, G. S., Satchwell, S. C., Seguin, C., etAll TRBP sites are contained within transcripts that tra-
al. (1984). DNA sequence and expression of the B95-8 Epstein–Barr
verse these elements (Baer et al., 1984). virus genome. Nature 310(5974), 207–211.
Blier, P. R., Griffith, A. J., Craft, J., and Hardin, J. A. (1993). Binding of KuPossible biological function of TRBPs
protein to DNA. Measurement of affinity for ends and demonstration
of binding to nicks. J. Biol. Chem. 268(10), 7594–7601.Since TRBPs bind the TRs at the locus of TR pro-
Boubnov, N. V., Hall, K. T., Wills, Z., Lee, S. E., He, D. M., Benjamin,cessing they may be involved in TR processing which
D. M., Pulaski, C. R., Band, H., Reeves, W., Hendrickson, E. A., et al.occurs twice in the life cycle of EBV: (1) during cleavage
(1995). Complementation of the ionizing radiation sensitivity, DNA
and packaging of the genome when virus is being pro- end binding, and V(D)J recombination defects of double-strand break
duced (Zimmermann and Hammerschmidt, 1995) and (2) repair mutants by the p86 Ku autoantigen. Proc. Natl. Acad. Sci. USA
92(3), 890–894.during circularization upon viral entry (Given et al., 1979;
Courey, A. J., and Tjian, R. (1988). Analysis of Sp1 in vivo reveals multipleKintner and Sugden, 1979b). Since cleavage and packag-
transcriptional domains, including a novel glutamine-rich activationing is an inducible activity, one of the final events prior
motif. Cell 55(5), 887–898.
to viral egress, it seems likely that this activity would be Craft, J., and Hardin, J. (1992). Immunoprecipitation assays for the detec-
under viral control. Although the DNA binding activity and tion of soluble nuclear and cytoplasmic nucleoproteins. In ‘‘Manual
abundance of TRBPs were unaffected by induction of the of Clinical Laboratory Immunology’’ (N. R. Rose, E. D. de Macario,
J. L. Fahey, H. Friedman, and G. M. Penn, Eds.), 4th ed, pp. 747–754.EBV lytic cycle, this binding does not exclude indirect
Am. Soc. Microbiol., Washington, DC.viral control on the action of the TRBPs via modification
Di Nocera, P. P., and Dawid, I. B. (1983). Transient expression of genesof the proteins or through interaction with other proteins.
introduced into cultured cells of Drosophila. Proc. Natl. Acad. Sci.
Sp1, Sp3, and Ku may also be involved in circulariza- USA 80(23), 7095–7098.
tion of the genome. Circularization of the genome occurs Dittmer, J., Gegonne, A., Gitlin, S. D., Ghysdael, J., and Brady, J. N. (1994).
Regulation of parathyroid hormone-related protein (PTHrP) gene ex-during the early stages of viral infection, within 16–20 hr
pression. Sp1 binds through an inverted CACCC motif and regulatespostinfection (Hurley and Thorley-Lawson, 1988) and is
promoter activity in cooperation with Ets1. J. Biol. Chem. 269(34),preceded by synthesis of latent viral products, such as
21428–21434.
the EBNAs. However, some cells are readily infected by Doyle, M. G., Catovsky, D., and Crawford, D. H. (1993). Infection of leu-
EBV and support EBNA production but do not efficiently kaemic B lymphocytes by Epstein–Barr virus. Leukemia 7(11), 1858–
1864.circularize the genome (Doyle et al., 1993; Walls et al.,
Errami, A., Smider, V., Rathmell, W. K., He, D. M., Hendrickson, E. A.,1989). For example, in studies examining activation and
Zdzienicka, M. Z., and Chu, G. (1996). Ku86 defines the genetic defectimmortalization of leukaemic B cells by EBV it was found
and restores X-ray resistance and V(D)J recombination to comple-
that chronic lymphocytic leukaemic (CLL) cells are resis- mentation group 5 hamster cell mutants. Mol. Cell Biol. 16(4), 1519–
tant to immortalization by EBV due to a low efficiency 1526.
of genome circularization. By contrast, prolymphocytic Gardella, T., Medveczky, P., Sairenji, T., and Mulder, C. (1984). Detection
of circular and linear herpesvirus DNA molecules in mammalian cellsleukemic (PLL) cells formed circular episomes efficiently
by gel electrophoresis. J. Virol. 50(1), 248–254.(Doyle et al., 1993; Walls et al., 1989). These studies
Given, D., Yee, D., Griem, K., and Kieff, E. (1979). DNA of Epstein–Barrsuggest that circularization is at least partly dependent
virus. V. Direct repeats of the ends of Epstein–Barr virus DNA. J.
upon cellular factors. Virol. 30(3), 852–862.
In conclusion, components of the TRBP complex have Gottlieb, T. M., and Jackson, S. P. (1993). The DNA-dependent protein
been identified as Sp1, Sp3, and Ku. These proteins were kinase: Requirement for DNA ends and association with Ku antigen.
Cell 72(1), 131–142.found to bind repeated sequences that are involved in
Grogan, E. A., Summers, W. P., Dowling, S., Shedd, D., Gradoville, L.,rearrangement events of the EBV genome. Of particular
and Miller, G. (1983). Two Epstein-Barr viral nuclear neoantigensinterest, Sp1 and Sp3 bound to sequences of the EBV
distinguished by gene transfer, serology, and chromosome binding.
TR with high affinity. These proteins may act as trans- Proc. Natl. Acad. Sci. USA 80(24), 7650–7653.
factors in TR processing and possibly in cellular recombi- Gussander, E., and Adams, A. (1984). Electron microscopic evidence
nation. These results emphasize that Sp1 and Sp3 may for replication of circular Epstein–Barr virus genomes in latently
infected Raji cells. J. Virol. 52(2), 549–556.have functions in addition to transcriptional activation
Hagen, G., Muller, S., Beato, M., and Suske, G. (1992). Cloning by(Marin et al., 1997).
recognition site screening of two novel GT box binding proteins: A
family of Sp1 related genes. Nucleic Acids Res. 20(21), 5519–5525.ACKNOWLEDGMENTS
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